Abstract:Background Hypertension is one of the most urgent public health challenges, and drug therapy is the primary method to control blood pressure for patients. However, blood pressure control rate is still poor with antihypertensive drugs use. Although Clinical Prediction Rules (CPR) is useful to help clinicians make more appropriate decisions at the point of medication, the evidence is still limited in china. The objective of this study is to develop an CPR of antihypertensive drugs in individualized application of patients based on real-world practice. Methods A two-way cohort study has been conducted in one China’s large tertiary hospital using clinical information on patient characteristics, drug use and clinical outcome. Data extraction is through ICD-10 disease codes of hypertension from Electronic Medical Record System. Eligible patients admitted from September 2016 to August 2018 who have received at least one antihypertensive drug therapy is included. Patients were grouped into several exposure groups according to medications. COX regression model and clinical specialty survey is applied to identify Influencing Factors (IF) in different study groups, and the discriminant model was used to construct a CPR according IF. The accuracy of the CPR is analyzed by sensitivity, specificity, Youden’s index and Receiver Operating Characteristic (ROC) curve. Discussion Result is expected to provide valuable CPR for physicians and policymakers with respect to treating hypertension according characteristic of individual patients. By developing a predictive method for clinical outcomes and treatment costs of antihypertensive medication, we expect to discriminate those patients who would profit from specific scheme of antihypertensive drugs to minimal incidence probability of costs and complications in region of china. Trial registration This study was registered at [www.chictr.org][1] as a primary register of the WHO International Clinical Trials Registry Platform (ICTRP), and the registered number is ChiCTR1900026339. Highlights Although Clinical Prediction Rules (CPR) could recognize individual patient risk and help clinicians to make more appropriate decision at the point of medication as part of clinical decision support systems, the evidence in this respect is still limited in China. This study is first going to construct the CPR of multiple antihypertensive drugs in real world practice of China. The highlights of this study is aimed to provide a pragmatic method to support clinical decisions for patients who has received antihypertensive drugs before long-term diagnosis of hypertension in real world practice according to their characteristics that are accessible to clinicians. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial ChiCTR1900026339 ### Funding Statement Not applicable. ### Author Declarations All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript. Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes The datasets used and/or analysis during the current study are available from the corresponding author on reasonable request. * CPR : Clinical Prediction Rules CDSS : Clinical Decision Support Systems AHD : Antihypertensive drugs (AHD) AI : Artificial intelligence IF : Influencing Factors EMRC : Electronic Medical Record System DALY : Disability-Adjusted Life Year [1]: http://www.chictr.org

Supporting clinical evidence for national medical insurance drug list selection: A case of antihypertensive drugs of class A

Evidence for the effectiveness of anti-hypertensive medicines included on the Chinese National Reimbursement Drug List.

Evidence-based Research on the Selection Method System for China's Essential Medicine List

Trends and Patterns of Five Antihypertensive Drug Classes Between 2007 and 2012 in China Using Hospital Prescription Data

CEA Comprehensive Evaluation for Western and Traditional Chinese Hypotensive Drugs

Gap Between Evidence and Physicians' Knowledge and Practice Regarding Hypertension and Its Drug Treatment: A Survey in A Chinese City

Developing an Individualized Clinical Prediction Rules of Antihypertensive Drugs: A Study Protocol Based on Real-world Practice

Current prescription status of antihypertensive drugs in Chinese patients with hypertension: analysis by type of comorbidities

Efficacy of Pharmacological Monotherapies for Type 2 Diabetes in China: A Systematic Review and Meta-Analysis

Hypertension in China: the Gap Between Policy and Practice

Triangulating Evidence for Antihypertensive Drug Class Efficacy on Cardiovascular and Metabolic Outcomes Using Mendelian Randomisation and Colocalisation

Evaluation of blood pressure lowering effect by generic and brand-name antihypertensive drugs treatment: a multicenter prospective study in China

Chinese patent medicine combined with calcium channel blockers in the treatment of essential hypertension:a Bayes network meta-analysis and systematic review

Investigation of drug use in newly-diagnosed hypertensive outpatients in secondary and tertiary hospitals in China

Utilization of oral antihypertensive drugs in Beijing University Hospital

Analysis of Adherence to Antihypertensive Drugs in Chinese Patients with Hypertension: A Retrospective Analysis Using the China Health Insurance Association Database.

Level of evidence supporting the Chinese cardiovascular disease clinical practice guidelines and its evolution in the past two decades

Antihypertensive Drugs Use Over A 5-Year Period Among Children And Adolescents In Beijing, China An Observational Study

Tianma Gouteng Decoction combined with Qiju Dihuang Pill for the treatment of essential hypertension: A protocol for systematic review and meta-analysis

How willing are the public to pay for anti-hypertensive drugs for primary prevention of cardiovascular disease: a survey in a Chinese city.

[Network Meta-analysis of efficacy and safety of oral Chinese patent medicines combined with conventional western medicine in treatment of hypertension].